Dr. Renxi Wang is a neuroimmunologist, professor, and lab director in Laboratory of Neuroimmunology, Beijing Institute of Brain Disorders, Capital Medical University. Dr. Wang mainly studies lymphocyte differentiation and function, and potential therapeutic targets for immune-related diseases including Parkinson's Disease, Alzheimer's Disease, multiple sclerosis, type I diabetes, uveitis, systemic lupus erythematosus, multiple myeloma, sepsis, viral H7N9 infectious diseases, paraquat poisoning. Particular interest is on cytokine signaling that regulate lymphocyte development and cell-fate decisions. The ultimate goal is to develop targeted therapy for immune-related diseases. Dr. Wang has got eight grants (RMB > 10 millions) funded by National Science and Technology Major Project, National Nature and Science Fund and Beijing Natural Science Foundation. The Dr. Wang group has published more than 100 important scientific articles (Nat Med, J Infect, J Med Virol, Nat Commun, Cancer Res, Crit Care Med, Cell Mol Immunol, Mol Ther) with more than 600 impact factors and 3000 citations (h-index: 28). Dr. Wang serves as a supervisor and has instructed 2 postdoctoral fellow, 8 Ph.D. and 8 masters. Dr. Wang is an editorial board member for several scientific journals. He also serves as a reviewer for funding agencies including Chinese National Nature and Science Funds, the Beijing Natural Science Foundation, Czech Science Foundation, National Youth Ten Thousand Talents Plan, and scientific journals such as Cell Mol Immunol, J Cell Mol Med, Oncotarget, Mol Immunol.